Assay News and Research

RSS

Adenovirus and mRNA COVID vaccines differ in 6-month antibody durability

Research compares the durability of neutralizing antibody responses among recipients of three different COVID-19 vaccines (BNT162b2, mRNA-1273, and Ad26.COV2.S) over a period of 6 months.

11 May 2023

Ketogenic diet's surprising impact on opioid sensitivity and withdrawal

Research investigates the effects of a ketogenic diet (KD) on responses to oxycodone, a commonly prescribed opioid for pain management. The study found sex-biased effects of KD on oxycodone responses in mice, suggesting potential implications for clinical pain management and treatment of opioid use disorder.

10 May 2023

New study finds elevated inflammatory cytokines and lymphocytes linked to rare cases of myocarditis after COVID-19 vaccination

Researchers investigated a cohort of patients who developed myocarditis after SARS-CoV-2 mRNA vaccination.

10 May 2023

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

Research paper reports the results of a phase 3 clinical trial evaluating the efficacy and safety of the FINLAY-FR-2 and FINLAY-FR-1A vaccines in Iranian adults.

7 May 2023

Cancer stem cell test can lead to increased survival for patients with glioblastoma

New multi-institutional phase 3 clinical trial data published May 2 in Cell Reports Medicine found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.

5 May 2023

The Human Protein Atlas and Precision Medicine

In this interview, Mathias Uhlen, the Director of the Human Protein Atlas, talks to NewsMed about the Human Protein Atlas and Precision Medicine.

From MGI 4 May 2023

Is an increase in cortisol levels associated with impaired working-memory retrieval and recognition in students?

Researchers examined the memory scores and electroencephalogram profiles of students to understand exam-induced stress and anxiety among the student population.

4 May 2023

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.

From Gyros Protein Technologies AB 4 May 2023

Wildlife in Britain found free of SARS-CoV-2, but novel virus discovered in stoats

Scientists in the United Kingdom have conducted a large-scale screening for sarbecoviruses and pan-coronaviruses in British Wildlife to investigate the occurrence of widespread spillover events. They have identified a novel minacovirus in stoats recently introduced to the Orkney Islands.

3 May 2023

Study examines the reinfection of SARS-CoV-2 variants in children

Study suggests the zoonotic-like avian H3N8 virus has limited efficiency for human-to-human transmission and is unlikely to cause severe disease in humans

Researchers demonstrated that the novel and avian hemagglutinin 3 neuraminidase 8 (H3N8) virus showed limited replication in explant cultures of lung and bronchial tissue.

27 Apr 2023

Assay News and Research

Adenovirus and mRNA COVID vaccines differ in 6-month antibody durability

Ketogenic diet's surprising impact on opioid sensitivity and withdrawal

New study finds elevated inflammatory cytokines and lymphocytes linked to rare cases of myocarditis after COVID-19 vaccination

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

Cancer stem cell test can lead to increased survival for patients with glioblastoma

The Human Protein Atlas and Precision Medicine

Is an increase in cortisol levels associated with impaired working-memory retrieval and recognition in students?

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Wildlife in Britain found free of SARS-CoV-2, but novel virus discovered in stoats

Study examines the reinfection of SARS-CoV-2 variants in children

Can smoking cigarettes alter your bone structure?

Cats and COVID-19: measuring seroprevalence against SARS-CoV-2 in domestic cats

Study identifies immune signature to predict severe COVID-19 in cardiovascular patients

A high proportion of adults in Europe do not have protective antibody concentrations against diphtheria

Evaluating the association between Mediterranean Diet adherence and type 2 diabetes using nutritional biomarkers

Urgent call for improved diagnostics, treatments, and vaccines against deadly Hantavirus

The BCG vaccine does not decrease the risk of COVID-19 in healthcare workers

Discovery of new biomarkers could lead to early detection of bladder cancer

New strategy for identifying small molecules offers a promising path for discovering targeted drugs

Study suggests the zoonotic-like avian H3N8 virus has limited efficiency for human-to-human transmission and is unlikely to cause severe disease in humans

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News